One of the recent research developments in the area of mesothelioma and lung cancer is the possibility of a new vaccine.  My clients and their loved ones are looking at new ways to fight these aggressive cancers.  Vaccinations may be one part of a multimodal treatment plan.  We are hopeful that vaccines may be one of the advancements we have been waiting for.

Researchers are predicting that a new therapeutic vaccine for non-small cell lung cancer could be available in one to three years.  These vaccines are now in late phase clinical trails.  The vaccines may be used with other traditional treatments such as radiation and chemotherapy.  Using the vaccines in combination with other modes of treatment may increase a patients’ quality of life, may increase life expectancy, and could decrease side effects and amounts of chemotherapy or radiation needed.  These findings were reported by ECRI Institute (an independent, non-profit organization that researches methods for improvements in patient care).

This research is important to the mesothelioma and lung cancer community because patients suffering from these diseases often have limited treatment options and poor prognosis (depending on stage of disease).  Research in the area of mesothelioma and asbestos-related disease is poorly funded and needs more attention.  This new research could mean increased advancements in treating mesothelioma and other asbestos-related cancers.

More information at www.medicalnewstoday.com.  Also check out this interesting article about research funding from a mesothelioma victim’s trust fund:  June Hancock: Ray of hope in cancer treatment.